相似文献
1
Managing the cost of cardiovascular prevention in primary care.
Heart. 2004 Jun;90 Suppl 4(Suppl 4):iv26-8; discussion iv39-40. doi: 10.1136/hrt.2004.037598.
2
Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databases.
Atherosclerosis. 2011 Aug;217(2):479-85. doi: 10.1016/j.atherosclerosis.2011.04.014. Epub 2011 Apr 22.
3
Resource implications and health benefits of primary prevention strategies for cardiovascular disease in people aged 30 to 74: mathematical modelling study.
BMJ. 2002 Jul 27;325(7357):197. doi: 10.1136/bmj.325.7357.197.
4
Cost-effectiveness of a cardiovascular disease primary prevention programme in a primary health care setting. Results of the Polish part of the EUROACTION project.
Kardiol Pol. 2013;71(7):702-11. doi: 10.5603/KP.2013.0157.
5
Costs of cardiovascular disease prevention care and scenarios for cost saving: a micro-costing study from rural Nigeria.
J Hypertens. 2015 Feb;33(2):376-684. doi: 10.1097/HJH.0000000000000402.
6
Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?
Eur J Prev Cardiol. 2012 Jun;19(3):474-83. doi: 10.1177/1741826711406616. Epub 2011 Apr 1.
7
The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):371-6. doi: 10.1097/HJR.0b013e328329497a.
8
A cash boost for tackling heart disease in primary care.
Community Nurse. 2000 Dec;6(11):5.
9
Cardiovascular disease in the elderly: current considerations.
Am J Cardiol. 1989 May 2;63(16):3H-4H. doi: 10.1016/0002-9149(89)90107-0.
10
The excess health care costs of KardioPro, an integrated care program for coronary heart disease prevention.
Health Policy. 2015 Jun;119(6):778-86. doi: 10.1016/j.healthpol.2015.01.012. Epub 2015 Jan 24.
引用本文的文献
1
Sugar sweetened beverages attributable disease burden and the potential impact of policy interventions: a systematic review of epidemiological and decision models.
BMC Public Health. 2021 Jul 27;21(1):1460. doi: 10.1186/s12889-021-11046-7.
2
The effect of screening for cardio-renal risk factors on drug use in the general population.
Br J Clin Pharmacol. 2007 Dec;64(6):810-8. doi: 10.1111/j.1365-2125.2007.02988.x.
本文引用的文献
1
Repeat prescribing: a role for community pharmacists in controlling and monitoring repeat prescriptions.
Br J Gen Pract. 2000 Apr;50(453):271-5.
2
Repeat prescribing management--a cause for concern?
Br J Gen Pract. 1999 May;49(442):343-7.
3
British Hypertension Society guidelines for hypertension management 1999: summary.
BMJ. 1999 Sep 4;319(7210):630-5. doi: 10.1136/bmj.319.7210.630.
4
Relationship between the number of partners in a general practice and the number of different drugs prescribed by that practice.
Br J Gen Pract. 1992 Jan;42(354):10-2.
Zotero 插件